SOD2 and vascular disorder: Dikalova et al. have reported that cardiovascular risk factors reduce the expression of SIRT3, thus contributing to SOD2 hyperacetylation, which leads to mROS generation and related vascular disorders, such as vascular inflammation and hypertension (25).